Resource Center
Resource Center
The revolutionary HIV prevention tool, injectable lenacapavir, will be available at a cost of US$40 a year in 120 low- and middle-income countries starting in 2027, under a new partnership announced today between Dr. Reddy’s Laboratories and Unitaid, the Clinton Health Access Initiative (CHAI), and Wits RHI.
Read more
As world leaders gather in New York this week for the UN High-Level Meeting on Non-Communicable Diseases and Mental Health, they’re confronting a stark reality: non-communicable diseases (NCDs) kill more people than any other cause globally yet receive only a fraction of health funding. But what if the solution isn’t just more money—what if it’s...
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
This white paper examines the opportunities and challenges for new manufacturers aiming to build globally competitive and commercially viable businesses in the low- and middle-income country vaccine markets.
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
Rwanda shows elimination is possible. But without urgent global action, treatment access could vanish—and lives with it.
Read more
Strategic three-year collaboration aims to improve public health outcomes through government-led digitization of campaigns and financial systems
Read more
MedAccess, Unitaid, and CHAI announce a new volume guarantee agreement between MedAccess and Synergy Gases Ltd (Synergy) to expand access to affordable oxygen for medical use across sub-Saharan Africa.
Read more
CHAI sessions at the International AIDS Society Summit 2025 in Kigali, Rwanda.
Read more